Ping An Biomedical: Market Performance and Corporate Actions
Market Performance
- Last closing price: USD 4.60 per share.
- 24‑hour change: Down 26.4 % (closing at 03:45 PM Central Europe, Friday 23 Oct 2026).
- Trading volume: Approximately USD 304.5 k traded in the last 24 hours.
- Shares outstanding: 127.9 million.
- Market capitalisation: USD 11.5 million.
- Price trend since month‑end: Decline of 29.23 %.
- 200‑day simple moving average: USD 0.16.
- 52‑week high: USD 0.77 on 28 Oct 2025.
- 52‑week low: USD 0.08 on 21 Oct 2026.
Corporate Actions
On 22 October 2026, Ping An Biomedical Co., Ltd. filed a Form 6‑K reporting the following:
- Extraordinary General Meeting – Scheduled for 29 October 2026.
- Proposals include:
- A 40:1 share consolidation.
- Adoption of a third amended memorandum of association.
- Increase in authorised capital.
- Additional share consolidations contingent on share‑price movements.
- Adoption of a fourth amended memorandum to reflect these changes.
- Board recommendation: “For” vote on all proposals.
- Shareholders may vote by proxy or in person.
- Intention to Acquire Patents – Letter of intent to purchase three oncology‑related patents from Future Biotechnology Group.
- Proposed consideration: a few million dollars.
- Deal remains at the letter‑of‑intent stage and is subject to due diligence, negotiation, and regulatory approval.
- No immediate revenue impact is anticipated; the patents are intended as a foundation for longer‑term biomedical initiatives.
Related Stock Performance (Last 24 Hours)
| Stock | 24‑Hour Change | Current Price | Market Capitalisation | Notes |
|---|---|---|---|---|
| Global Digital Creations Hol (8271.HK) | +4.23 % | HKD 0.07 | HKD 106.7 million | |
| Lifestyle China (2136.HK) | 0 % | HKD 0.56 | HKD 104.1 million | |
| Tvb (0511.HK) | –2.49 % | HKD 1.77 | HKD 108 million | P/E ratio: 8.99 |
| Altus / Hong Kong (8149.HK) | –0.78 % | HKD 0.13 | HKD 107.9 million | P/E ratio: 17.67 |
| Greenpro Capital (GRNQ) | +5.87 % | USD 7.15 | USD 13.4 million | Filed 22 Oct 2026; resignation of a board member, no material changes reported. |
The market reaction to Ping An Biomedical’s recent filing and the broader sectoral movements provide a snapshot of current investor sentiment and corporate governance developments within the biomedical and technology sectors.
